Volinia S, Calin G A,Liu C G, et al. A microRNA expression signature of human solid tumors defines cancer gene targets[J]. Proc Natl Acad Sci USA, 2006, 103(7): 2257.
[5]
Cesare Peschle. MicroRNAs control angiogenesis[J]. Blood,2006, 108(9): 3068.
[6]
陈可冀.关于高血压病的中西医结合研究[J].中国中西医结合杂志,2010,30(5): 453.
[7]
Yang Z, Kaye D M. Mechanistic insights into the link between a polymorphism of the 3\'UTR of the SLC7A1 gene and hypertension[J]. Hum Mutat,2009, 30(3): 328.
[8]
Yang Z, Venardos K, Jones E, et al. Identification of a novel polymorphism in the 3\'UTR of the L-arginine transporter gene SLC7A1: contribution to hypertension and endothelial dysfunction[J]. Circulation, 2007, 115(10): 1269.
[9]
Poliseno L, Tuccoli A, Mariani L, et al. MiRNAs modulate the angiogenic properties of HUVECs[J]. Blood, 2006, 108(9): 3068.
[10]
Cordes K R, Sheehy N T, White M P, et al. MiR-145 and miR-143 regulate smooth muscle cell fate and plasticity [J]. Nature, 2009, 460(7256): 705.
Mei Xin, Eric M Small, Lillian B Sutherland, et al. MicroRNAs miR-143 and miR-145 modulate cytoskeletal dynamics and responsiveness of smooth muscle cells to injury[J]. Genes Dev, 2009, 23: 2166.
[13]
Yu M L, Wang J F, Wang G K, et al. Vascular smooth muscle cell proliferation is influenced by let-7d microRNA and its interaction with KRAS[J]. Cir J, 2011, 75:703.
[14]
Chan M C, Hilyard A C, Wu C, et al. Molecular basis for antagonism betweenpdgf and the tgf beta family of signalling pathways by control of mir-24expression[J]. EMBO J, 2010, 29: 559.
[15]
Leeper N J, Raiesdana A, Kojima Y, et al. Microma-26a is a novel regulator of vascular smooth muscle cell function[J]. J Cell Physiol, 2011, 226(4): 1035.
[16]
Sethupathy P, Borel C, Gagnebin M, et al. Human microRNA-155 on chromosome 21 differentially interacts with its polymorphic target in the AGTR1 3\' untranslated region: a mechanism for functional single-nucleotide polymorphisms related to phenotypes[J]. Am J Hum Genet, 2007, 81(2): 405.
[17]
Martin M M, Lee E J, Buckenberger J A, et al. MicroRNA-155 regulates human angiotensinⅡtype1 receptor expression in fibroblasts[J]. J Biol Chem, 2006,281(27): 18277.
Mitchell P S, Parkin R K, KrohE M, et al.Circulating microRNAs as stable blood-based markers for cancer detection[J].Proc Natl Acad Sci USA, 2008, 105(30): 10513.
[20]
Li Shuqiang, Zhu Jianguo, Zhang Weili, et al. Signature microRNA expression profile of essential hypertension and its novel link to human cytomegalovirus infection[J]. Circulation, 2011, 124: 175.
Karolina D S, Tavintharan S, Armugam A, et al. Circulating miRNA profiles in patients with metabolic syndrome[J]. J Clini Endocrinol Metabol, 2012, 97(12): 2271.
Wang J, Xiong X J. Current situation and perspectives of clinical study in integrative medicine in China[J]. Evid-Based Complement Alternat Med, 2012,doi: 10.1155/2012/268542.
[30]
Wang J, Xiong X J. Control strategy on hypertension in Chinese medicine [J]. Evid-Based Complement Alternat Med, 2012, doi: 10.1155/2012/284847.
Xiong X J, Yang X C, Liu Y M, et al. Chinese herbal formulas for treating hypertension in traditional Chinese medicine: perspective of modern science[J]. Hypert Res,2013, doi: 10.1038/hr.2013.18.
[35]
Xiong X J, Yang X C, Liu W, et al. Trends in the treatment of hypertension from the perspective of traditional Chinese medicine [J]. Evid-Based Complement Alternat Med, 2013, doi: 10.1155/2013/275279.
[36]
Wang J, Xiong X J. Evidence-based Chinese medicine for hypertension[J]. Evid-Based Complement Alternat Med, 2013, doi: 10.1155/2013/978398.
[37]
Wang J, Xiong X J. Outcome measures of Chinese herbal medicine for hypertension: an overview of systematic reviews[J]. Evid-Based Complement Alternat Med,2012, doi: 10.1155/2012/697237.
[38]
Mottl A K, Shoham D A, North K E. Angiotensin II type 1 receptor polymorphisms and susceptibility to hypertension: a huge review[J]. Genet Med, 2008, 10(8): 560.
[39]
Yael Nossent A, Hansen J L, Doggen C, et al. SNPs in microRNA binding sites in 3\'-UTRs of RAAS genes influence arterial blood pressure and risk of myocardial infarction[J]. Am J Hypertens, 2011, 24(9): 999.
[40]
Berger S, Bleich M, Schmid W, et al. Mineralocorticoid receptor knockout mice: pathophysiology of Na+ metabolism[J]. Proc Natl Acad Sci USA, 1998, 95(16): 9424.
[41]
Sber S, Laan M, Annilo T. MicroRNAs miR-124 and miR-135a are potential regulators of the mineralocorticoid receptor gene (NR3C2) expression[J]. Biochem Biophys Res Commun, 2010, 391(1): 727.
[42]
Sándor Bátkai, Thomas Thum. MicroRNAs in hypertension: mechanisms and therapeutic targets[J]. Curr Hypertens Rep, 2012, 14:79.
